13F filing recap · Q3 2009

What did ValueAct Capital buy in Q3 2009?

Reported stock-position changes between this filing and the previous one.

Stock value

$2.56B

Positions

Estimated turnover

33.9%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

BCRC.r. Bard, Inc.$110.97Mreported value+1.41M shares VRSNVeriSign Inc/ca$59.34Mreported value+2.50M shares GPROGen-Probe Inc$53.07Mreported value+1.28M shares

Increased positions

VRXValeant Pharmaceuticals International, Inc.$498.79Mreported value+746.9K shares+4.4%WSHWillis Group Holdings Plc$163.28Mreported value+2.35M shares+68.4%IMAInverness Medical Innovations, Inc.$132.22Mreported value+729.9K shares+27.2%IU1Immucor Inc$65.76Mreported value

Reduced positions

BFHBread Financial Holdings, Inc.$205.37Mreported value-350.5K shares-9.4%TRIThomson Reuters Corporation$189.02Mreported value-6.52M shares-53.7%EFXEquifax Inc$112.41Mreported value-5.73M shares-59.8%

Exited positions

SWYSafeway Inc$13.71Mprior reported value-673.3K shares-100.0%IDCInteractive Data Corp$13.19Mprior reported value-570.0K shares-100.0%HOTStarwood Hotels & Resorts Worldwide Inc$4.44Mprior reported value-200.0K shares-100.0%XRAYDentsply Sirona Inc.$3.36Mprior reported value